A patient asks the nurse to tell her more about a new drug the patient has been prescribed called ranolazine (Ranexa). Which response by the nurse is accurate?
This drug does not reduce blood pressure or heart rate.
This drug is a first-line therapy for angina.
This drug must be given intravenously.
Ranexa is safe to use in patients with liver failure.
The Correct Answer is A
Choice A rationale
Ranolazine (Ranexa) is an antianginal agent that works by inhibiting the late sodium current in cardiac myocytes. This inhibition leads to a reduction in intracellular calcium overload, improving myocardial relaxation and reducing ventricular wall tension. Unlike many other antianginal drugs, ranolazine does not significantly affect heart rate or blood pressure, making it useful in patients who cannot tolerate the hemodynamic effects of other agents.
Choice B rationale
Ranolazine is not a first-line therapy for angina. It is typically used as a second-line treatment in patients who have not achieved adequate symptom control with beta-blockers, calcium channel blockers, or nitrates. It is often prescribed in combination with other antianginal drugs.
Choice C rationale
Ranolazine is an oral medication available in an extended-release tablet formulation. It is not administered intravenously. The patient takes this medication by mouth, usually twice daily, for the long-term management of chronic angina.
Choice D rationale
Ranexa is metabolized by the liver, specifically via the cytochrome P450 3A (CYP3A) enzyme pathway. Therefore, it is contraindicated or requires significant dose adjustment in patients with moderate to severe hepatic impairment due to the risk of increased plasma concentrations and toxicity.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Choice A rationale
Alpha blockers primarily exert their effects on the vascular smooth muscle by blocking alpha-1 adrenergic receptors. This action leads to vasodilation, which lowers blood pressure. They do not have a direct mechanism of action that would precipitate acute renal failure upon first dose administration. Renal function, while monitored, is not the most immediate or common adverse effect to assess for.
Choice B rationale
Alpha-1 adrenergic receptors, when blocked by alpha blockers, cause vasodilation of both arteries and veins. This leads to a decrease in peripheral vascular resistance and venous return, causing a significant drop in blood pressure. This effect, known as orthostatic hypotension or "first-dose phenomenon," is a common and critical adverse effect to assess for, as it can cause dizziness and fainting.
Choice C rationale
Blood dyscrasias, or disorders involving the cellular components of blood, are not a typical or immediate adverse effect associated with the first administration of an alpha blocker. While some medications can cause these rare side effects over long-term use, the acute and most common concern with the initial dose is related to its cardiovascular effects on blood pressure.
Choice D rationale
While alpha blockers can indirectly affect the heart rate through baroreceptor reflexes in response to hypotension, they are not typically associated with the direct induction of significant dysrhythmias as a primary adverse effect upon first administration. The immediate and most profound hemodynamic effect is the peripheral vasodilation and subsequent hypotension, which takes precedence in initial assessment.
Correct Answer is A
Explanation
Choice A rationale
Radioactive iodine (RAI) therapy involves the administration of a radioactive isotope of iodine, I-131, which is selectively taken up by the thyroid gland to destroy overactive thyroid cells. Since the patient's body contains radioactive material, they must follow strict precautions to prevent radiation exposure to others. This includes avoiding close contact with pregnant women and young children for several days to weeks, as they are more susceptible to the harmful effects of radiation.
Choice B rationale
This is incorrect. Patients are generally advised to stop taking antithyroid medications, such as methimazole or propylthiouracil, several days before RAI therapy. These drugs prevent the thyroid gland from utilizing iodine, which would interfere with the uptake of the radioactive iodine, rendering the treatment ineffective. The goal is to maximize the absorption of the radioactive iodine by the thyroid gland.
Choice C rationale
This is incorrect. A patient preparing for radioactive iodine therapy must follow a low-iodine diet for one to two weeks before the treatment. High-iodine foods would saturate the thyroid gland with non-radioactive iodine, competing with the radioactive iodine for uptake and significantly reducing the efficacy of the therapy. Limiting iodine intake ensures the thyroid is "hungry" for the radioactive isotope.
Choice D rationale
While increasing fluid intake is generally a healthy practice, it is not a primary safety instruction for radioactive iodine therapy. The main instruction is to drink fluids and urinate frequently after the procedure. This helps to flush any unabsorbed radioactive iodine from the body more quickly, reducing radiation exposure to other parts of the body, particularly the bladder.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
